Table 1. Correlation between AFAP1-AS1 level and clinicopathological characteristics in cervical cancer patients.
| Characteristics | n | AFAP1-AS1 expression | p value | |
|---|---|---|---|---|
| Low | High | |||
| Age (Years) | 0.731 | |||
| ≥60 | 32 | 18 | 14 | |
| <60 | 28 | 12 | 16 | |
| Sex | 0.556 | |||
| Male | 25 | 11 | 14 | |
| Female | 35 | 19 | 16 | |
| Tumor size (mm) | 0.256 | |||
| ≥30 | 40 | 17 | 23 | |
| <30 | 20 | 13 | 7 | |
| TNM stage | 0.001 | |||
| I--II | 28 | 22 | 6 | |
| III--IV | 32 | 8 | 24 | |
| Histological grade | 0.238 | |||
| Well | 29 | 15 | 14 | |
| Moderate-poor | 31 | 15 | 16 | |
| Lymph node metastasis | 0.008 | |||
| Positive | 41 | 14 | 27 | |
| Negative | 19 | 16 | 3 | |
| Distant metastasis | 0.012 | |||
| Positive | 29 | 9 | 20 | |
| Negative | 31 | 21 | 10 | |
Note: The expression of AFAP1-AS1 was significantly related to distant metastasis, lymph node metastasis, and TNM stage (all p < 0.05), although it was not statistically correlated with histological grade, tumor size, sex, or age (all p > 0.05) in cervical cancer patients. Taken together, AFAP1-AS1 was highly expressed in cervical cancer patients with higher TNM stage, positive lymph node metastasis, and positive distant metastases. The bolded text in Table meant p < 0.05.